FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * LICHTINGER PEDRO   2. Issuer Name and Ticker or Trading Symbol BIOTIME INC [BTX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 1301 HARBOR BAY PARKWAY 3. Date of Earliest Transaction (Month/Day/Year) 06/04/2013 (Street) ALAMEDA, CA 94502 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Shares, no par value 06/04/2013   P   120,000 A (1) 126,250 (2) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Option to Purchase Common Shares

$ 5

06/04/2013

P

30,000

06/04/2013

06/04/2018

Common Shares

30,000

$ 0

30,000

D

Option to Purchase Common Shares

$ 4.6

(3)

06/30/2017

Common Shares

20,000

20,000

D

Option to Purchase Common Shares

$ 5.13

(4)

06/30/2016

Common Shares

20,000

20,000

D

Option to Purchase Common Shares

$ 5.45

(5)

08/09/2015

Common Shares

20,000

20,000

D

Option to Purchase Common Shares

$ 3.45

(6)

08/10/2014

Common Shares

20,000

20,000

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LICHTINGER PEDRO 1301 HARBOR BAY PARKWAY ALAMEDA, CA 94502	X

Signatures

/s/ Pedro Lichtinger		06/06/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On June 4, 2013, Mr. Lichtinger purchased 120,000 BioTime common shares and 30,000 options to purchase 30,000 common shares in a private transaction. Each common share and one quarter of each option were purchased for an aggregate price of $4.155.
(2)	Does not include shares that may be acquired upon the exercise of certain stock options.
(3)	5,000 options became exercisable on September 30, 2012; December 31, 2012;and March 31, 2013. 5,000 options will become exercisable on June 30, 2013 based upon continued service on the board of directors.
(4)	5,000 options became exercisable on September 30, 2011; December 31, 2011; March 31, 2012; and June 30, 2012.
(5)	5,000 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
(6)	5,000 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.